Skip to content
Xintela logotyp
  • Projects
    • Technology Platform
    • Pipeline
    • Stem Cell Therapy
    • Targeted cancer therapy
    • Indications
    • Publications
  • Investors
    • Share Information
    • Financial Reports
    • Financial Calendar
    • Analyses
    • Share issues
    • Management & Board
    • Corporate Governance
    • General Meetings
    • IR Contact / Certified Adviser
  • Media
    • Press Releases
    • Xintelling – Newsletter
    • Videos
    • Xintela in the news
    • Events
  • About Xintela
  • Contact
Targinta logotyp
  • SV
Xintela logotyp
Targinta logotyp
  • SV
Xintela logotyp
  • SV

Xintela has completed a directed new share issue raising proceeds of approximately SEK 28 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, CANADA, JAPAN, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE IN ACCORDANCE WITH APPLICABLE […]

Xintela intends to carry out a directed share issue through an accelerated book building procedure

Lund, 2021-06-16 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, CANADA, JAPAN, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE IN ACCORDANCE […]

Contact Info

Xintela AB
Medicon Village
223 81 Lund, Sweden
+46 46 275 65 00
info@xintela.se

Reg. No: 556780-3480
VAT No: SE556780348001

Privacy- & Cookie Policy

Visitors address

Scheeletorget 1, Lund

Business & administration

Evy Lundgren-Åkerlund CEO
evy@xintela.se

IR & Media

ir@xintela.se

Subscribe to press releases, reports, newsletters and analyses.

© 2026 Xintela AB | All Rights Reserved
  • Projects
    • Technology Platform
    • Pipeline
    • Stem cell therapy
    • Targeted cancer therapy
    • Indications
    • Publications
  • Investors
    • Share Information
    • Financial Reports
    • Financial Calendar
    • Analyses
    • Share issues
    • Management & Board
    • Corporate Governance
    • General Meetings
    • IR-contact / Certified Adviser
  • Media
    • Press Releases
    • Xintelling – Newsletter
    • Videos
    • Xintela in the news
    • Events
  • About Xintela
  • Contact
Targinta logotyp
  • Research & Development
    • Integrin α10β1
    • Pipeline
    • TARG9
    • TARG10
    • Cancer Indications
  • About Targinta
    • Management & Board
    • Business Development
    • Invest
  • Contact
Xintela logotyp